Yunbo Xie

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

Lei Shi, Xin Yuan, Weiqi Yao et al. · EBioMedicine · 2021 · 120 citations · Full text

Medicine, Clinical Sciences, Radiology +14

Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients

Xiangsheng Xu, Qinghua Shang, Xinyue Chen et al. · Cellular and Molecular Immunology · 2015 · 111 citations · Full text

Life Sciences, Immunology, Internal Medicine +15

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

Fanping Meng, Jinfang Zhao, Anthony T. Tan et al. · Hepatology International · 2021 · 108 citations · Full text

Medicine, Immunology, Oncology +16

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

Anthony T. Tan, Fanping Meng, Jiehua Jin et al. · Hepatology Communications · 2021 · 28 citations · Full text

Medicine, Immunology, Oncology +17

Protective Effect of Molecular Hydrogen Following Different Routes of Administration on D-Galactose-Induced Aging Mice

Boyan Liu, Yunbo Xie, Jun Chen et al. · Journal of Inflammation Research · 2021 · 24 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17